Abstract: The Medium Access Control (MAC) layer of Wireless Local Area Networks (WLANs) undergoes several amendments since the birth of the legacy standard IEEE 802.11. The legacy standard IEEE 802.11 ...
SAN FRANCISCO, Oct 22 (Reuters) - Google said it has developed a computer algorithm that points the way to practical applications for quantum computing and will be able to generate unique data for use ...
For consumers trying to compare the costs of owning a gas-powered vehicle versus an EV, there is enough information out there to make their heads spin. One analyst has tried to break through the noise ...
The VGChartz sales comparison series of articles are updated monthly and each one focuses on a different sales comparison using our estimated video game hardware figures. The charts include ...
Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. Visa (NYSE: V), a world leader in digital payments, is ...
The UK Information Commissioner's Office (ICO) has fined genetic testing provider 23andMe £2.31 million ($3.12 million) over 'serious security failings' that led to a 'profoundly damaging' data breach ...
Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company’s sale of its customers’ genetic data without explicit consent. The suit, filed this ...
More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to auction off personal genetic information without their customers’ knowledge or ...
Tarrytown-based Regeneron would acquire 23andMe for $256 million under the deal that is pending approval by bankruptcy court and regulators. New York-based biotech giant Regeneron Pharmaceuticals ...
Genetic data was on the auction block, and a U.S. biotech company ponied up the cash. New York-based Regeneron Pharmaceuticals announced on Monday that it has purchased DNA testing company 23andMe ...
Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, including its biobank of customer genetic samples, have been purchased by ...
In a deal raising significant privacy concerns, biotechnology giant Regeneron Pharmaceuticals announced Monday it is acquiring embattled consumer genetics company 23andMe out of bankruptcy for $256 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback